Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Duensing

Showing results (101-110 of 139) with videos related to

Pageof 14
Sort By:
Nature Reviews. Urology|November 30, 2022
Experimental in vitro, ex vivo and in vivo models in prostate cancer researchVerena Sailer, Gunhild von Amsberg, Stefan Duensing, et al.
Cancers|February 25, 2022
Impact of Surgeon's Experience in Rigid versus Elastic MRI/TRUS-Fusion Biopsy to Detect Significant Prostate Cancer Using Targeted and Systematic CoresMagdalena Görtz, Joanne Nyaboe Nyarangi-Dix, Lars Pursche, et al.
International Journal of Cancer|July 5, 2019
Increased mediator complex subunit CDK19 expression associates with aggressive prostate cancerFinn Becker, Vincent Joerg, Marie C Hupe, et al.
Oncotarget|April 16, 2016
MERTK as a novel therapeutic target in head and neck cancerAnne von Mässenhausen, Christine Sanders, Britta Thewes, et al.
Frontiers in Medicine|October 17, 2017
Prognostic Value of the New Prostate Cancer International Society of Urological Pathology Grade GroupsAnne Offermann, Silke Hohensteiner, Christiane Kuempers, et al.
Scientific Reports|July 6, 2017
Mutations in BRCA2 and taxane resistance in prostate cancerCathleen Nientiedt, Martina Heller, Volker Endris, et al.
The Journal of Biological Chemistry|September 5, 2020
Actin-binding protein profilin1 promotes aggressiveness of clear-cell renal cell carcinoma cellsAbigail Allen, David Gau, Paul Francoeur, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 12, 2019
Patients Resistant Against PSMA-Targeting α-Radiation Therapy Often Harbor Mutations in DNA Damage-Repair-Associated GenesClemens Kratochwil, Frederik L Giesel, Claus-Peter Heussel, et al.
EJNMMI Reports|November 7, 2024
Enhancing the diagnostic capacity of [<sup>18</sup>F]PSMA-1007 PET/MRI in primary prostate cancer staging with artificial intelligence and semi-quantitative DCE: an exploratory studyPhilip Alexander Glemser, Martin Freitag, Balint Kovacs, et al.
Journal of Endourology|July 9, 2015
The Impact of Magnetic Resonance Imaging on Prediction of Extraprostatic Extension and Prostatectomy Outcome in Patients with Low-, Intermediate- and High-Risk Prostate Cancer: Try to Find a StandardJan Philipp Radtke, Boris A Hadaschik, Maya B Wolf, et al.
Pageof 14

Showing results (101-110 of 139) with videos related to

Sort By:
Pageof 14
Nature Reviews. Urology|November 30, 2022
Experimental in vitro, ex vivo and in vivo models in prostate cancer researchVerena Sailer, Gunhild von Amsberg, Stefan Duensing, et al.
Cancers|February 25, 2022
Impact of Surgeon's Experience in Rigid versus Elastic MRI/TRUS-Fusion Biopsy to Detect Significant Prostate Cancer Using Targeted and Systematic CoresMagdalena Görtz, Joanne Nyaboe Nyarangi-Dix, Lars Pursche, et al.
International Journal of Cancer|July 5, 2019
Increased mediator complex subunit CDK19 expression associates with aggressive prostate cancerFinn Becker, Vincent Joerg, Marie C Hupe, et al.
Oncotarget|April 16, 2016
MERTK as a novel therapeutic target in head and neck cancerAnne von Mässenhausen, Christine Sanders, Britta Thewes, et al.
Frontiers in Medicine|October 17, 2017
Prognostic Value of the New Prostate Cancer International Society of Urological Pathology Grade GroupsAnne Offermann, Silke Hohensteiner, Christiane Kuempers, et al.
Scientific Reports|July 6, 2017
Mutations in BRCA2 and taxane resistance in prostate cancerCathleen Nientiedt, Martina Heller, Volker Endris, et al.
The Journal of Biological Chemistry|September 5, 2020
Actin-binding protein profilin1 promotes aggressiveness of clear-cell renal cell carcinoma cellsAbigail Allen, David Gau, Paul Francoeur, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 12, 2019
Patients Resistant Against PSMA-Targeting α-Radiation Therapy Often Harbor Mutations in DNA Damage-Repair-Associated GenesClemens Kratochwil, Frederik L Giesel, Claus-Peter Heussel, et al.
EJNMMI Reports|November 7, 2024
Enhancing the diagnostic capacity of [<sup>18</sup>F]PSMA-1007 PET/MRI in primary prostate cancer staging with artificial intelligence and semi-quantitative DCE: an exploratory studyPhilip Alexander Glemser, Martin Freitag, Balint Kovacs, et al.
Journal of Endourology|July 9, 2015
The Impact of Magnetic Resonance Imaging on Prediction of Extraprostatic Extension and Prostatectomy Outcome in Patients with Low-, Intermediate- and High-Risk Prostate Cancer: Try to Find a StandardJan Philipp Radtke, Boris A Hadaschik, Maya B Wolf, et al.
Pageof 14